Found: 12
Select item for more details and to access through your institution.
Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Droxidopa for the Short- Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (n OH306 B).
- Published in:
- Movement Disorders, 2015, v. 30, n. 5, p. 646, doi. 10.1002/mds.26086
- By:
- Publication type:
- Article
Psychometric validation of a patient-reported single-item assessment of 'Good Day Bad Day' in a neurogenic orthostatic hypotension population treated with droxidopa.
- Published in:
- Journal of Market Access & Health Policy, 2022, v. 10, n. 1, p. 1, doi. 10.1080/20016689.2021.2010961
- By:
- Publication type:
- Article
Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease.
- Published in:
- Movement Disorders Clinical Practice, 2018, v. 5, n. 6, p. 627, doi. 10.1002/mdc3.12695
- By:
- Publication type:
- Article
Characterization of the symptoms of neurogenic orthostatic hypotension and their impact from a survey of patients and caregivers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of the Norepinephrine Prodrug Droxidopa on the QTc Interval in Healthy Individuals.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 3, p. 332, doi. 10.1002/cpdd.393
- By:
- Publication type:
- Article
Characterization of the changes in supine blood pressure with long-term use of droxidopa in patients with neurogenic orthostatic hypotension.
- Published in:
- Health Science Reports, 2021, v. 4, n. 1, p. 1, doi. 10.1002/hsr2.227
- By:
- Publication type:
- Article
Comparison of the Pharmacokinetics of Droxidopa After Dosing in the Fed Versus Fasted State and with 3-Times-Daily Dosing in Healthy Elderly Subjects.
- Published in:
- Drugs in R&D, 2018, v. 18, n. 1, p. 77, doi. 10.1007/s40268-018-0226-z
- By:
- Publication type:
- Article
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment.
- Published in:
- Neurology & Therapy, 2022, v. 11, n. 1, p. 459, doi. 10.1007/s40120-021-00317-5
- By:
- Publication type:
- Article
A Call to Action: The Role of Healthcare Providers in Reducing the Burden Associated with Neurogenic Orthostatic Hypotension.
- Published in:
- Neurology & Therapy, 2020, v. 9, n. 2, p. 205, doi. 10.1007/s40120-020-00203-6
- By:
- Publication type:
- Article